Increased incidence of infections following the late introduction of mycophenolate mofetil in renal transplant recipients

Abstract

There is significant morbidity associated with an increased incidence of infection after late introduction of MMF at standard doses in renal transplant recipients. This risk may be related to GFR at the time of conversion.